Oakland's Rotation Thinned as Leiter Jr. Heads to IL Before Deadline

The Athletics placed right-hander Mark Leiter Jr. on the 15-day injured list retroactive to July 19, sidelining him with a right hip impingement. Infielder Joshua Kuroda-Grauer landed on the 10-day IL following surgery for a ruptured testicle. Oakland recalled righty Hayden Juenger and infielder Max Muncy to cover the roster holes, but the timing matters: Leiter Jr. was a logical deadline candidate, a controllable cost-controlled arm on an expiring contract that contending teams covet in July. The injury window—just 10 days before the trade deadline at the end of the month—severely limits Oakland's leverage and Leiter Jr.'s trade value.

Leiter Jr. has carried a 3.64 ERA over 15 starts this season with a 8.4 K/9 and 2.9 BB/9, a solid mid-rotation profile that fits the deadline-acquisition archetype. The hip impingement is not structurally catastrophic, but it's the kind of injury that stalls momentum: he'll miss at least two starts, possibly three depending on recovery pace. If he returns before the deadline, Oakland gains minimal leverage—buyers will demand a discount for medical uncertainty, knowing he's just cleared a soft-tissue ailment. If he doesn't return by July 31, he's simply off the market.

From a betting lens, Oakland's bullpen usage pattern shifts immediately. Juenger's arrival signals the club expects to lean harder on relief depth with Leiter Jr. unavailable. This matters for bullpen K-prop correlations and reliever innings ceilings over the next two weeks: Oakland will compress starter innings and push more leverage into a pen that's already logged heavy work in July. Look for increased reliance on Oakland's top relief arms, potentially elevating their strikeout rates as the team chases wins in a division race.

Kuroda-Grauer's absence is a secondary detail—he's a utility piece—but the surgical nature of his injury means he's unlikely to return before early August. Oakland's infield depth was already thin. The combo of these losses ahead of the deadline also signals organizational priorities: if the team were buyers, these injuries would sting differently than if they're sellers. The July 31 window is now a constraint on both roster flexibility and asset liquidity. Leiter Jr. either rehabs into a late-month return with no trade value, or the Athletics quietly shelve deadline ambitions.